For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

The US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device.

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

RxDx Device for non-small cell lung cancer has received Breakthrough Device Designation from the U.S. Food and Drug ...

April 22 (UPI) -- Biotechnology giant Roche said it will invest $50 billion into the United States over the next five years.

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

Roche posted higher first-quarter sales that beat analysts’ expectations on higher demand for its key drugs. The Swiss ...

Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.

Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...